Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-study-illustrates-haemostatic-powder-can-be-used-as-first-line-endoscopic-treatment-in-patients-with-active-upper-gastrointestinal-bleeding
https://www.med.cuhk.edu.hk/press-releases/cuhk-study-illustrates-haemostatic-powder-can-be-used-as-first-line-endoscopic-treatment-in-patients-with-active-upper-gastrointestinal-bleeding

CUHK study illustrates haemostatic powder can be used as first-line endoscopic treatment in patients with active upper gastrointestinal bleeding

A study conducted by The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine), in collaboration with King Chulalongkorn Memorial University Hospital in Thailand and Changi General Hospital in Singapore, has discovered that a unique haemostatic powder, namely TC-325, can be used as a first-line endoscopic treatment in patients with active upper gastrointestinal bleeding. The study showed that bleeding was controlled within 30 days in 90% of TC-325-treated patients, which means TC-325 is as good as standard treatment. 

 

This is the world’s first randomised clinical trial with a sufficient sample size to compare TC-325 monotherapy treatment with the standard one. Details of the study have been published in the renowned journal Annals of Internal Medicine.

 

Upper gastrointestinal bleeding is one of the most common medical emergencies

 

Upper gastrointestinal bleeding is one of the most common medical emergencies with an annual incidence of approximately 130 per 100,000 adults in Hong Kong. The symptoms of which include hematemesis, melena, or both. Patients need to undergo endoscopy for haemostatic treatment. Current treatment includes the use of clips, contact thermocoagulation for peptic ulcers and argon plasma coagulation for diffuse vascular lesions and tumours.

 

TC-325 is a bentonite haemostatic powder with aluminium phyllosilicate clay as the main ingredient. When in contact with blood, the absorbent forms an adherent barrier at the bleeding site. The powder was used in stopping bleeding from external wounds. About 10 years ago, the Institute of Digestive Disease at CUHK reported the first endoscopic application of TC-325. Since then, it has been used as a rescue therapy in patients in whom standard treatment failed to control bleeding.

 

TC-325 has the advantage of being technically easy to apply and is particularly good for treating a diffuse oozing haemorrhage from a larger area such as in bleeding gastrointestinal cancers. This new study aims to prove the effectiveness of the powder as a single endoscopic treatment.

 

The haemostatic powder group has 90% of patients with bleeding controlled

 

A total of 224 patients from Hong Kong, Thailand and Singapore were enrolled in this study. All patients were randomly assigned to the 2 study groups, with 111 patients treated with TC-325 while the others received standard treatment.

 

Key results of the study are as follows:

 

TC-325 group
(111 patients)

Standard treatment group
(113 patients)

Patients with bleeding controlled within 30 days (patients)

100 (90%)

92 (81%)

Recurrent bleeding after initial endoscopic control (patients)

9 (8%)

10 (9%)

Needed additional interventions within 30 days (patients)

8 (7%)

10 (9%)

 

The research teamconcluded that the study shows TC-325 is not inferior to standard treatment in the endoscopic control of bleeding from nonvariceal upper gastrointestinal causes. In addition to being used as a rescue therapy, TC-325 can also be considered as a first-line endoscopic treatment for this kind of bleeding.       

More Press Releases

CUHK Study Finds Earlier Endoscopy Did Not Reduce Mortality and Risk of Further Bleeding in Acute Upper Gastrointestinal Bleeding Patients

CUHK Study Finds Earlier Endoscopy Did Not Reduce Mortality and Risk of Further Bleeding in Acute Upper Gastrointestinal Bleeding Patients

Research
CU Medicine and Olympus Corporation sign MoU to develop  innovative endoscopy and laparoscopy technologies

CU Medicine and Olympus Corporation sign MoU to develop innovative endoscopy and laparoscopy technologies

Surgical advancement
CU Medicine proves a new ultrasound-guided endoscopic procedure has higher success and shorter procedural time for treating malignant distal biliary obstruction

CU Medicine proves a new ultrasound-guided endoscopic procedure has higher success and shorter procedural time for treating malignant distal biliary obstruction

Research
CUHK finds over-the-scope clips are more effective than standard treatment for patients with non-variceal upper gastrointestinal bleeding

CUHK finds over-the-scope clips are more effective than standard treatment for patients with non-variceal upper gastrointestinal bleeding

Research
CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection  Using Flexible Endoscopic Robotic System

CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection Using Flexible Endoscopic Robotic System

Surgical advancement
CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

Research
CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Welcomes Government’s Proposal on Bowel Cancer Screening Territory-wide Bowel Cancer Screening Programme Shows 14% of Participants Diagnosed with Bowel Cancer or Pre-cancer

CUHK Welcomes Government’s Proposal on Bowel Cancer Screening Territory-wide Bowel Cancer Screening Programme Shows 14% of Participants Diagnosed with Bowel Cancer or Pre-cancer

Research
CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

Research
CUHK Successfully Performed Hong Kong's First Robotic Endoscopic Scarless Surgery - A Major Endoscopic Technological Breakthrough

CUHK Successfully Performed Hong Kong's First Robotic Endoscopic Scarless Surgery - A Major Endoscopic Technological Breakthrough

Surgical advancement
CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

Research
Why is Liver Cancer More Prevalent in Men than in Women? CUHK Discovers a Sex Hormone-controlled Gene that Promotes Liver Cancer

Why is Liver Cancer More Prevalent in Men than in Women? CUHK Discovers a Sex Hormone-controlled Gene that Promotes Liver Cancer

Research
CUHK Introduces Double Balloon Enteroscopy Service to Manage Small Bowel Diseases

CUHK Introduces Double Balloon Enteroscopy Service to Manage Small Bowel Diseases

Clinical service
CUHK Pioneers Scarless Per-oral Endoscopic Myotomy for Treatment of Esophageal Motility Disorders in Hong Kong

CUHK Pioneers Scarless Per-oral Endoscopic Myotomy for Treatment of Esophageal Motility Disorders in Hong Kong

Surgical advancement

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.